UnitedHealth Group Incorporated
UNH · NYSE
UNH · NYSE
The supplied consensus is Buy across 23 analysts, but its target statistics are internally inconsistent: the stated low and high are both $450, while the mean is $488.50. Other supplied forecast pages report averages of $463.93, $477.72 and $482.64, using different analyst counts and without establishing a comparable, dated range. Baird is the least bullish named firm in the snippets, with a $427 target after cutting it from $453 and retaining Neutral; the evidence does not identify the most bullish individual analyst. The only explicit named target revision is Baird's cut, but it is undated, so a direction of revisions during this week cannot be established. The stated disagreement centers on valuation and assumptions about Medicare and Optum Health margin recovery.
| Firm | Analyst | Rating | Price Target | Upside | Date | Source |
|---|---|---|---|---|---|---|
| Morgan Stanley | — | $468 | +15.9% | Jun 30, 2026 | Open the report this row came from | |
| Morgan Stanley | — | $468 | +15.9% | Jun 30, 2026 |
| B of A Securities | — | $450 | +11.4% | Jun 4, 2026 | Open the report this row came from |
| Bernstein | — | $492 | +21.8% | May 27, 2026 | Open the report this row came from |
